United States - English - NLM (National Library of Medicine)

watson laboratories, inc. - nandrolone decanoate (unii: h45187t098) (nandrolone - unii:6pg9vr430d) - injection - nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. surgically induced anephric patients have been reported to be less responsive. - male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate. male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate. - carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. - pregnancy, because of masculinization of the fetus. pregnancy, because of masculinization of the fetus. - nephrosis or the nephrotic phase of nephritis. nephrosis or the nephrotic phase of nephritis. nandrolone decanoate injection is classified as a schedule iii controlled substance under the anabolic steroids control act of

United States - English - NLM (National Library of Medicine)

american regent, inc. - nandrolone decanoate (unii: h45187t098) (nandrolone - unii:6pg9vr430d) - nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. surgically induced anephric patients have been reported to be less responsive. - male patients with carcinoma of the breast or with known or suspected carcinoma of the prostate. - carcinoma of the breast in females with hypercalcemia: androgenic anabolic steroids may stimulate osteolytic resorption of bones. - pregnancy, because of masculinization of the fetus. - nephrosis or the nephrotic phase of nephritis. nandrolone decanoate injection is classified as a schedule iii controlled substance under the anabolic steroids control act of 1990.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rwr veterinary products pty ltd - nandrolone decanoate - unknown - nandrolone decanoate steroid-anabolic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - nandrolone decanoate - unknown - nandrolone decanoate steroid-anabolic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rwr veterinary products pty ltd - nandrolone decanoate - parenteral liquid/solution/suspension - nandrolone decanoate steroid-anabolic active 50.0 mg/ml - endocrine system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - anabolic steroid | abortion threat | androgenic properties | bone repair | catabolic complications | convalescence | erythropoietic activity | geriatric therapy | improve appetite | male sexual characterisitics | muscle development | non-virilising anabolic | pathophysiological process | protein and mineral anabolic | skeletal conditions | tissue breakdown | tissue repair | virilising anabolic

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - nandrolone decanoate; oestradiol dipropionate; hydroxy progesterone hexanoate - parenteral liquid/solution/suspension - nandrolone decanoate steroid-anabolic active 80.0 mg/ml; oestradiol dipropionate steroid-estrogen active 2.0 mg/ml; hydroxy progesterone hexanoate steroid-progestin active 80.0 mg/ml - endocrine system - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - anabolic steroid | abortion threat | androgenic properties | bone repair | catabolic complications | convalescence | erythropoietic activity | geriatric therapy | improve appetite | male sexual characterisitics | muscle development | non-virilising anabolic | pathophysiological process | protein and mineral anabolic | skeletal conditions | tissue breakdown | tissue repair | virilising anabolic

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rwr veterinary products pty ltd - nandrolone decanoate; oestradiol dipropionate; hydroxy progesterone hexanoate - parenteral liquid/solution/suspension - nandrolone decanoate steroid-anabolic active 80.0 mg/ml; oestradiol dipropionate steroid-estrogen active 1.3 mg/ml; hydroxy progesterone hexanoate steroid-progestin active 80.0 mg/ml - endocrine system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - anabolic steroid | abortion threat | androgenic properties | bone repair | catabolic complications | convalescence | erythropoietic activity | geriatric therapy | improve appetite | male sexual characterisitics | muscle development | non-virilising anabolic | pathophysiological process | protein and mineral anabolic | skeletal conditions | tissue breakdown | tissue repair | virilising anabolic

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nandrolone decanoate, quantity: 50 mg/ml - injection, solution - excipient ingredients: arachis oil; benzyl alcohol - indications as at 16 april 1997. acute renal failure, chronic renal insufficiency and anaemia of chronic renal failure. for the palliative treatment of inoperable mammary carcinoma. osteoporosis (where oestrogen therapy is contraindicated). aplastic anaemia. patients on long-term treatment with corticosteriods.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - nandrolone decanoate 25 mg/ml - solution for injection - 25 mg/ml - active: nandrolone decanoate 25 mg/ml excipient: arachis oil benzyl alcohol - deca-durabolin can be used for the treatment of osteoporosis; for the palliative treatment of selected cases of disseminated mammary carcinoma in women and as an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - nandrolone decanoate 50 mg/ml - solution for injection - 50 mg/ml - active: nandrolone decanoate 50 mg/ml excipient: arachis oil benzyl alcohol - deca-durabolin can be used for the treatment of osteoporosis; for the palliative treatment of selected cases of disseminated mammary carcinoma in women and as an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance.